Mitral regurgitation cardiac catheterization: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Gerald Chi (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
{| class="infobox" style="float:right;" | {| class="infobox" style="float:right;" | ||
|- | |- | ||
| [[File:Siren.gif|30px|link=Mitral | | [[File:Siren.gif|30px|link=Mitral regurgitation resident survival guide]]|| <br> || <br> | ||
| [[Mitral | | [[Mitral regurgitation resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | ||
|} | |||
{| class="infobox" style="float:right;" | |||
|- | |||
| [[File:Critical_Pathways.gif|88px|link=Mitral regurgitation critical pathways]]|| <br> || <br> | |||
|} | |} | ||
{{Mitral regurgitation}} | {{Mitral regurgitation}} | ||
{{CMG}}; | {{CMG}}; {{AE}} [[User:Mohammed Sbeih|Mohammed A. Sbeih, M.D.]] [mailto:msbeih@wikidoc.org] | ||
==Overview== | ==Overview== |
Revision as of 23:27, 18 August 2013
Resident Survival Guide |
File:Critical Pathways.gif |
Mitral Regurgitation Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mitral regurgitation cardiac catheterization On the Web |
American Roentgen Ray Society Images of Mitral regurgitation cardiac catheterization |
Risk calculators and risk factors for Mitral regurgitation cardiac catheterization |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed A. Sbeih, M.D. [2]
Overview
In patients with mitral regurgitation who have risk factors for coronary artery disease, such as advanced age, hypercholesterolemia, and hypertension, or when there is a suspicion that mitral regurgitation is ischemic in origin, coronary angiography should be performed before surgery.
2008 and Incorporated 2006 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease (DO NOT EDIT) [1]
Cardiac Catheterization Indications (DO NOT EDIT) [1]
Class I |
"1. Left ventriculography and hemodynamic measurements are indicated when noninvasive tests are inconclusive regarding severity of MR, LV function, or the need for surgery.(Level of Evidence: C) " |
"2. Hemodynamic measurements are indicated when pulmonary artery pressure is out of proportion to the severity of MR as assessed by noninvasive testing.(Level of Evidence: C) " |
"3. Left ventriculography and hemodynamic measurements are indicated when there is a discrepancy between clinical and noninvasive findings regarding severity of MR.(Level of Evidence: C) " |
"4. Coronary angiography is indicated before mitral valve repair or mitral valve replacement in patients at risk for CAD.(Level of Evidence: C) " |
Class III |
"1. Left ventriculography and hemodynamic measurements are not indicated in patients with MR in whom valve surgery is not contemplated.(Level of Evidence: C) " |
Sources
- 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease [1]
References
- ↑ 1.0 1.1 1.2 Bonow RO, Carabello BA, Chatterjee K; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172. Unknown parameter
|month=
ignored (help)